T cells with high BCL-2 expression induced by venetoclax impact anti-leukemic immunity "graft-versus-leukemia effects"

Blood Cancer J. 2024 May 14;14(1):79. doi: 10.1038/s41408-024-01064-0.

Joji Nagasaki^#^{1

2}, Mitsutaka Nishimoto^#³, Hideo Koh^{1

4}, Hiroshi Okamura^{1

5}, Mika Nakamae^{1

5}, Kazuki Sakatoku¹, Kentaro Ido^{1

5}, Masatomo Kuno¹, Yosuke Makuuchi¹, Teruhito Takakuwa¹, Yasuhiro Nakashima¹, Masayuki Hino¹, Hirohisa Nakamae¹

¹ Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
² Department of Tumor Microenvironment, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
³ Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. nishimo@omu.ac.jp.
⁴ Department of Preventive Medicine and Environmental Health, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
⁵ Department of Laboratory Medicine and Medical Informatics, Osaka Metropolitan University, Osaka, Japan.

^# Contributed equally.

No abstract available

Publication types